![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Yongtai Chiral Medicine Technology Co., Ltd. Taizhou City Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Carbidopa, Site Yongtai Chiral, Process A, non-micronised, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2024-003 - Rev 00
This Chemical Type CEP, issued on March 19, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 755 associated with this CEP further emphasizes